Long-Term Prognosis and Treatment Strategy of Persistent PSA After Radical Prostatectomy.

Takahiro KomoriKazuhiro MatsumotoTakeo KosakaToshikazu TakedaRei KamitaniYota YasumizuNobuyuki TanakaShinya MoritaRyuichi MizunoHiroshi AsanumaMototsugu Oya

Published in: Annals of surgical oncology (2023)

SVI and nadir PSA ≥1.0 ng/mL are independent risk factors for CRPC in patients with persistent PSA after RP. Salvage RT is considered to be the optimal treatment for this condition.

Keyphrases

radical prostatectomy
prostate cancer
replacement therapy